Dec 02, 2024
Revolution Medicines Shares Drop on Clinical Data Update
On Monday, Revolution Medicines, Inc. (NASDAQ:RVMD) stock declined 10% following an update on clinical data. The company, focused on developing therapies for RAS-addicted cancers,...